Urine glucose tetrasaccharide: A good biomarker for glycogenoses type II and III? A study of the French cohort
Main Authors: | Monique Piraud, Magali Pettazzoni, Marie de Antonio, Christine Vianey-Saban, Roseline Froissart, Brigitte Chabrol, Sarah Young, Pascal Laforêt |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Molecular Genetics and Metabolism Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221442692030029X |
Similar Items
-
Glucose-6-phosphatase deficiency
by: Labrune Philippe, et al.
Published: (2011-05-01) -
LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease.
by: Magali Pettazzoni, et al.
Published: (2017-01-01) -
P188: Urine glucose tetrasaccharide as a potential pharmacodynamic biomarker for the development of new treatments for glycogen storage disease type III*
by: Rachael Hawtin, et al.
Published: (2023-01-01) -
Creation and implementation of a European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC registry)
by: Tomàs Pinós, et al.
Published: (2020-10-01) -
French recommendations for the management of glycogen storage disease type III
by: Camille Wicker, et al.
Published: (2023-07-01)